Kombiglyze Class Action Lawsuit
Update: DPP-4 Inhibitors Linked to Rhabdomyolysis December 1, 2017 – Diabetes patients who took DPP-4 inhibitors like Kombiglyze XR have been diagnosed with a rare muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...
Onglyza Class Action Lawsuit
Update: Onglyza Heart Failure Lawsuits Centralized in Kentucky February 5, 2018 – JPML has voted to consolidate all federal lawsuits alleging heart failure injuries from Onglyza and Kombiglyze XR for pretrial handling in the Eastern District of Kentucky. The Panel...
Invokana Kidney Failure Class Action Lawsuit
Update: Invokana Kidney Failure Lawsuit Filed in New Jersey May 1, 2017 – A New Jersey woman who allegedly developed an acute kidney injury that led to end-stage renal disease (kidney failure) less than 2 months after taking Invokana for...
Invokana Heart Attack Class Action Lawsuit
Recent studies have linked the type 2 diabetes medication Invokana to cardiovascular side effects including blood clots that could lead to a heart attack. Free Invokana Class Action Lawsuit Evaluation: If you or a loved one was injured by Invokana,...
Xigduo XR Class Action Lawsuit
Update: Xigduo XR Litigation Centralized in New York April 13, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered that all federal lawsuits involving Farxiga and Xigduo XR be centralized for pretrial handling in the Southern District...
Glyxambi Class Action Lawsuit
Glyxambi may be Linked to Rhabdomyolysis, FDA Warns December 1, 2017 – The U.S. Food & Drug Administration (FDA) is investigating a potential link between Glyxambi and other type 2 diabetes medications in its class and a severe muscular condition...
Invokamet Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokamet May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...
Invokana Class Action Lawsuit
Update: FDA Requires Boxed Warning on Amputation Risk with Invokana May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as...
Talcum Powder Class Action Lawsuit
Talcum Powder has been linked to the increased risk of ovarian cancer. Our lawyers are representing women and their families who have been diagnosed with cancer after using talcum powder personal hygiene products. Learn more about your legal rights and...